Log in

Relevant bibliographies by topics / MBD3 / Books

To see the other types of publications on this topic, follow the link: MBD3.

Books on the topic 'MBD3'

Author: Grafiati

Published: 4 June 2021

Last updated: 27 April 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 27 books for your research on the topic 'MBD3.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Salomon, Fred. Praxisbuch Ethik in der Notfallmedizin: Orientierungshilfen für kritische Entscheidungen. Berlin: MWV Medizinisch Wissenschaftliche Verlagsgesellschaft, 2015.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Tikkanen, Märta. Sofia vuxen med sitt MBD. 2nd ed. [Stockholm]: Forum, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Virtanen, Timo. Parenting stress and coping among mothers with MBD children. Rovaniemi: University of Lapland, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Hyperactivity, the so-called attention-deficit disorder, and the group of MBD syndromes. Cresskill, N.J: Creative Therapeutics, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Agency, United States Minority Business Development. QA: Answers to questions about MBDA's business assistance to minority entrepreneurs : MBDA-assisted entrepreneurship provides jobs, economic growth. [Washington, D.C.]: U.S. Dept. of Commerce, Minority Business Development Agency, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

QA: Answers to questions about MBDA's business assistance to minority entrepreneurs : MBDA-assisted entrepreneurship provides jobs, economic growth. [Washington, D.C.]: U.S. Dept. of Commerce, Minority Business Development Agency, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

United States. Minority Business Development Agency. QA: Answers to questions about MBDA's business assistance to minority entrepreneurs : MBDA-assisted entrepreneurship provides jobs, economic growth. [Washington, D.C.]: U.S. Dept. of Commerce, Minority Business Development Agency, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

International Seminar on Mineral Business Development (2004 Nagpur, India). International Seminar on Mineral Business Development: January 16-17, 2004, Nagpur, India : proceedings MBD 2004. Edited by Rajau K. S and Indian Bureau of Mines. [Nagpur: Mineral Information and Development Centre, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Agency, United States Minority Business Development. Minority Business Development Centers (MBDC) Program: Competitive application kit (to be used for awards beginning October 1, 1991, or later). [Washington, D.C.?]: U.S. Dept. of Commerce, [Minority Business Development Agency, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Jung, Benjamin Ping. Investigations of the methyl CpG binding domain-containing factor MBD3 in neuronal development and neuronal differentiation. 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Statistics, Office for National. Congenital Anomaly Statistics (Series MB3). Stationery Office Books, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

Britain, Great. Congenital Malformation Statistics (Series MB3). Stationery Office Books, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

Statistics, Office for National. Congenital Anomaly Statistics (Series MB3). Stationery Office Books, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

Population Censuses & Surveys Office. Congenital Malformation Statistics Notifications (Series MB3). Stationery Office Books, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

Office, Population Censuses &. Surveys. Congenital Malformation Statistics Notifications (Series MB3). Stationery Office Books, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

Population Censuses & Surveys Office. Congenital Malformation Statistics Notifications (Series MB3). Stationery Office Books, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Tso. Congenital Anomaly Statistics: Notifications, 1997 (Series MB3). Stationery Office Books (TSO), 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Systems, Franklin Medical Book. Pocket PDR Mbd with the Washington Manual. Rittenhouse Book Distributors, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

Tso. Congenital Anomaly Statistics: Notifications 1999 (Opcs Series Mb3, 14). Stationery Office, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

Sprague, Stuart M., and Menaka Sarav. Chronic kidney disease-mineral and bone disorder. Edited by David J. Goldsmith. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199592548.003.0115_update_001.

Full text

Abstract:

The kidneys play a critical role in maintaining normal serum calcium and phosphorus concentrations, under the regulation of three main hormones: parathyroid hormone, calcitriol, and fibroblast growth factor 23. With the progression of chronic kidney disease (CKD), most patients develop CKD–mineral and bone disorder (CKD-MBD), which is a systemic disorder involving derangement in mineral metabolism, renal osteodystrophy, and extraskeletal calcification. Disturbances in mineral metabolism develop early in CKD and include phosphate retention, hypocalcaemia, vitamin D deficiency, and hyperparathyroidism. Renal osteodystrophy involves pathologic changes of bone morphology related to progressive CKD and is quantifiable by histomorphometry, based on bone biopsy. CKD-MBD is associated with significant morbidity, including bone loss, fractures, cardiovascular disease, immune suppression, as well as increased mortality. As the disorder begins early in the course of CKD, a proactive approach with intervention is important. Therapeutic strategies could then be employed to prevent and correct these disturbances, aiming to improve cardiovascular outcomes and survival. Current practice guidelines for CKD-MBD are based on insufficient data and high-quality studies are required before specific treatment can be advocated strongly.

APA, Harvard, Vancouver, ISO, and other styles

22

Tso. Congenital Malformation Statistics: Notifications, 1994 (Opcs Series Mb3 , Vol 10). Stationery Office, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

Biggar, Patrick, Hansjörg Rothe, and Markus Ketteler. Epidemiology of calcium, phosphate, and parathyroid hormone disturbances in chronic kidney disease. Edited by David J. Goldsmith. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199592548.003.0109_update_001.

Full text

Abstract:

Chronic kidney disease-mineral and bone disorders (CKD-MBD), calcium, phosphate, and parathyroid hormone are biomarkers of mortality and cardiovascular risk. Hyperphosphataemia is a prominent and pathophysiologically most plausible risk indicator. Calcium balance and load appear to be more important than serum concentrations. Parathyroid hormone is a less reliable marker with a relatively wide range extending above that applicable for a normal population especially when used as a singular laboratory parameter without additional assessment of bone metabolism, for example, bone-specific alkaline phosphatase and bone biopsy. There is not a single prospective controlled hard-outcome study that provides us with unequivocal evidence that such an isolated laboratory parameter-based treatment approach will lead to significant clinical improvements. As CKD-MBD is complex, clinical decisions would be made easier by informative prospective trials.

APA, Harvard, Vancouver, ISO, and other styles

24

Elder, Grahame J. Metabolic bone disease after renal transplantation. Edited by Jeremy R. Chapman. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0288.

Full text

Abstract:

Patients who undergo kidney transplantation have laboratory, bone, and soft tissue abnormalities that characterize chronic kidney disease mineral and bone disorder (CKD-MBD). After successful transplantation, abnormal values of parathyroid hormone, fibroblast growth factor 23, calcium, phosphate, vitamin D sterols, and sex hormones generally improve, but abnormalities often persist. Cardiovascular risk remains high and is influenced by prevalent vascular calcification, and fracture risk increases due to a combination of abnormal bone ‘quality’, compounded by immunosuppressive drugs and reductions in bone mineral density. Patients with well managed CKD-MBD before transplantation generally have a smoother post-transplant course, and it is useful to assess patients soon after transplantation for risk factors relevant to the general population and to patients with CKD. Targeted laboratory assessment, bone densitometry, and X-ray of the spine are useful for guiding therapy to minimize post-transplant effects of CKD-MBD. To reduce fracture risk, general measures include glucocorticoid dose minimization, attaining adequate 25(OH)D levels, and maintaining calcium and phosphate values in the normal range. Calcitriol or its analogues and antiresorptive agents such as bisphosphonates may protect bone from glucocorticoid effects and ongoing hyperparathyroidism, but the efficacy of these therapies to reduce fractures is unproven. Alternate therapies with fewer data include denosumab, strontium ranelate, teriparatide, oestrogen or testosterone hormone replacement therapy, tibolone, selective oestrogen receptor modulators, and cinacalcet. Parathyroidectomy may be necessary, but is generally avoided within the first post-transplant year. A schema is presented in this chapter that aims to minimize harm when allocating therapy.

APA, Harvard, Vancouver, ISO, and other styles

25

Tung, Hsiang-Lung. Design, analysis and implementation of the primary operation, retrieve-common, of the multi-backend-database system (MBDS). 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

Brophy, Peter. Libraries Without Walls 4: The Delivery of Library Services to Distant Users (Series MB3). Library Assn Pub Ltd, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

27

Nikolov, Igor G. The New Kidney and Bone Disease: Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD). INTECH Open Access Publisher, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!